179 related articles for article (PubMed ID: 7538520)
1. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications.
Grossman J; Banov C; Boggs P; Bronsky EA; Dockhorn RJ; Druce H; Findlay SR; Georgitis JW; Hampel FC; Kaiser H
J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1123-7. PubMed ID: 7538520
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%.
Kaiser HB; Findlay SR; Georgitis JW; Grossman J; Ratner PH; Tinkelman DG; Roszko P; Zegarelli E; Wood CC
J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1128-32. PubMed ID: 7751529
[TBL] [Abstract][Full Text] [Related]
3. Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial.
Finn AF; Aaronson D; Korenblat P; Lumry W; Settipane G; Spector S; Woehler T; Drda K; Wood CC
Am J Rhinol; 1998; 12(6):441-9. PubMed ID: 9883302
[TBL] [Abstract][Full Text] [Related]
4. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
Dockhorn R; Aaronson D; Bronsky E; Chervinsky P; Cohen R; Ehtessabian R; Finn A; Grossman J; Howland W; Kaiser H; Pearlman D; Sublett J; Ratner P; Settipane G; Sim T; Storms W; Webb R; Drda K; Wood C
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):349-59. PubMed ID: 10227333
[TBL] [Abstract][Full Text] [Related]
5. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.
Bronsky EA; Druce H; Findlay SR; Hampel FC; Kaiser H; Ratner P; Valentine MD; Wood CC
J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1117-22. PubMed ID: 7751528
[TBL] [Abstract][Full Text] [Related]
6. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology.
Meltzer EO; Orgel HA; Bronsky EA; Findlay SR; Georgitis JW; Grossman J; Ratner P; Wood CC
J Allergy Clin Immunol; 1992 Aug; 90(2):242-9. PubMed ID: 1386857
[TBL] [Abstract][Full Text] [Related]
7. Ipratropium nasal spray in children with perennial rhinitis.
Meltzer EO; Orgel HA; Biondi R; Georgitis J; Milgrom H; Munk Z; Van Bavel J; Wood CC; Drda K
Ann Allergy Asthma Immunol; 1997 May; 78(5):485-91. PubMed ID: 9164362
[TBL] [Abstract][Full Text] [Related]
8. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
Georgitis JW; Banov C; Boggs PB; Dockhorn R; Grossman J; Tinkelman D; Roszko P; Wood C
Clin Exp Allergy; 1994 Nov; 24(11):1049-55. PubMed ID: 7874603
[TBL] [Abstract][Full Text] [Related]
9. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine.
Baroody FM; Majchel AM; Roecker MM; Roszko PJ; Zegarelli EC; Wood CC; Naclerio RM
J Allergy Clin Immunol; 1992 Jun; 89(6):1065-75. PubMed ID: 1535082
[TBL] [Abstract][Full Text] [Related]
10. The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis.
Kaiser HB; Findlay SR; Georgitis JW; Grossman J; Ratner PH; Tinkelman DG; Wood CC
Allergy Asthma Proc; 1998; 19(1):23-9. PubMed ID: 9532321
[TBL] [Abstract][Full Text] [Related]
11. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions.
Wagenmann M; Baroody FM; Jankowski R; Nadal JC; Roecker-Cooper M; Wood CC; Naclerio RM
Clin Exp Allergy; 1994 Mar; 24(3):288-90. PubMed ID: 8012861
[TBL] [Abstract][Full Text] [Related]
12. The anticholinergic treatment of allergic perennial rhinitis.
Georgitis JW
J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1071-6. PubMed ID: 1460210
[TBL] [Abstract][Full Text] [Related]
13. Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies.
Kim KT; Kerwin E; Landwehr L; Bernstein JA; Bruner D; Harris D; Drda K; Wanger J; Wood CC;
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):73-9. PubMed ID: 15702820
[TBL] [Abstract][Full Text] [Related]
14. Management of rhinitis--the specialist's opinion.
van Cauwenberge P
Clin Exp Allergy; 1998 Dec; 28 Suppl 6():29-33. PubMed ID: 9988432
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological management of perennial rhinitis.
Mygind N
Rhinol Suppl; 1991; 11():21-6. PubMed ID: 1716118
[No Abstract] [Full Text] [Related]
16. Intranasal anticholinergic therapy of rhinorrhea.
Meltzer EO
J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1055-64. PubMed ID: 1460208
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children.
Milgrom H; Biondi R; Georgitis JW; Meltzer EO; Munk ZM; Drda K; Wood CC
Ann Allergy Asthma Immunol; 1999 Aug; 83(2):105-11. PubMed ID: 10480582
[TBL] [Abstract][Full Text] [Related]
18. A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis.
Becker B; Borum S; Nielsen K; Mygind N; Borum P
Clin Otolaryngol Allied Sci; 1997 Apr; 22(2):132-4. PubMed ID: 9160925
[TBL] [Abstract][Full Text] [Related]
19. Optimizing treatment options.
Naclerio RM
Clin Exp Allergy; 1998 Dec; 28 Suppl 6():54-9. PubMed ID: 9988437
[TBL] [Abstract][Full Text] [Related]
20. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]